Enter your terms above and click the 'Search' button.

Showing articles 0 to 8 of 8 Filter Applied: practice guidelines (Click to remove) Myasthenia Gravis NEJM 375:2570-2581, Gilhus, N.E.,et al, 2016 Evidence-based Guideline: Intravenous Immunoglobulin in the Treatment of Neuromascular Disorders Neurol 78:1009-1015, Patwa,H.S.,et al, 2012 Evidence-Based Guideline Update: Plasmapheresis in Neurologic Disorders: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology Neurol 76:294-300, Cortese,I.,et al, 2011 Evidence-based Guideline: Clinical Evaluation and Treatment of Transverse Myelitis Neurol 77:2128-2134, Scott, T.F.,et al, 2011 Practice Parameter:Immunotherapy for Guillain-Barre Syndrome, Report of the Quality Standards Subcommittee of the American Academy of Neurology Neurol 61:736-740, Hughes,R.A.C.,et al, 2003 Disease Modifying Therapies in Multiple Sclerosis Neurol 58:169-178, Goodin,D.S.,et al, 2002 Assessment of Plasmapheresis Report of the Therapeutics and Technology Assessment Subcommittee of the AAN, Neurol 47:840-8431996., , 1996 Intracerebral Hemorrhage Associated with Oral Anticoagulant Therapy Stroke 37:256-262, Steiner, T.,et al, 2006 Showing articles 0 to 8 of 8